Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/217316
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMartinez Valenzuela, Laura-
dc.contributor.authorLino, Luis-
dc.contributor.authorGomez Preciado, Francisco-
dc.contributor.authorFulladosa, Xavier-
dc.contributor.authorCruzado, Josep Ma.-
dc.contributor.authorTorras Ambròs, Joan-
dc.contributor.authorDraibe, Juliana-
dc.date.accessioned2025-01-08T12:27:52Z-
dc.date.available2025-01-08T12:27:52Z-
dc.date.issued2024-05-01-
dc.identifier.issn1460-2385-
dc.identifier.urihttps://hdl.handle.net/2445/217316-
dc.descriptionComunicació/presentació a: 61st ERA Congress, The European Renal Association, Estocolm, 23-26 maig 2024-
dc.description.abstractImmune checkpoint inhibitors (ICI) have transformed cancer treatment, but they may lead to immune- mediated acute interstitial nephritis (ICI-AIN), in 2-5% of patients. About 35-40% show full kidney function recovery three months post ICI-AIN. Limited evidence exists for long-term renal toxicity.-
dc.format.extent2 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherOxford University Press (OUP)-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1093/ndt/gfae069.405-
dc.relation.ispartofNephrology Dialysis Transplantation, 2024, vol. 39, sup. 1, p. i668-i669-
dc.relation.urihttps://doi.org/10.1093/ndt/gfae069.405-
dc.rights(c) Martinez Valenzuela, Laura et al., 2024-
dc.sourceComunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationImmunoteràpia-
dc.subject.classificationMalalties del ronyó-
dc.subject.otherImmunotheraphy-
dc.subject.otherKidney diseases-
dc.titleLong-term renal outcomes in ICI-associated acute interstitial nephritis: a comprehensive comparative study-
dc.typeinfo:eu-repo/semantics/conferenceObject-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.date.updated2024-12-13T09:36:33Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
gfae069-0405-2754.pdf220.68 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.